-
COST-UTILITY ANALYSIS OF GLP-1 RECEPTOR AGONISTS VERSUS STANDARD CARE IN PATIENTS WITH CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME
Feb 25, 2026, 14:41 PM -
BUILDING RESILIENCY IN LIFE SCIENCES RESEARCH ORGANIZATIONS
Feb 25, 2026, 14:41 PM -
REAL-WORLD ONLINE CONVERSATIONS ON MASH/NASH: A ONE-YEAR SOCIAL MEDIA LISTENING ANALYSIS
Feb 25, 2026, 14:41 PM -
CLINICAL AND ECONOMIC IMPACT OF FARICIMAB-TREATED DIABETIC MACULAR EDEMA: A LINKED ANALYSIS OF ADMINISTRATIVE CLAIMS AND IRIS REGISTRY DATA
Feb 25, 2026, 14:41 PM -
MEASURING MEANINGFUL ENGAGEMENT: A PATIENT ENGAGEMENT METRICS FRAMEWORK FOR PATIENT-GENERATED PRIMARY DATA QUALITY
Feb 25, 2026, 14:41 PM -
A COMPARISON OF DIRECT MEDICAL COSTS IN VERTEBROPLASTY AND KYPHOPLASTY IN JAPAN AND IMPLICATIONS FOR IMPACTS ON THE BUDGET
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN SELF-REPORTED DEPRESSION AND MISSED MEDICATION DUE TO COST AMONG U.S. ADULTS: A 2024 BRFSS ANALYSIS
Feb 25, 2026, 14:41 PM -
A LIKELIHOOD-AUGMENTED VIRTUAL INCONSISTENCY-ADJUSTED ANALYSIS FRAMEWORK FOR ASSESSING ROBUSTNESS IN A STAR-SHAPED NETWORK META-ANALYSIS
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF LEBRIKIZUMAB VERSUS NEMOLIZUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE US: A 10-YEAR ECONOMIC EVALUATION
Feb 25, 2026, 14:41 PM -
A SYSTEMATIC REVIEW OF ONCOLYTIC VIRUSES AND GENE THERAPIES FOR RETINOBLASTOMA IN CHILDREN
Feb 25, 2026, 14:41 PM -
HEALTHCARE RESOURCE UTILIZATION AMONG PEOPLE LIVING WITH HIV BEFORE AND AFTER THE COVID-19 PANDEMIC IN THE UNITED STATES: A DESCRIPTIVE ANALYSIS
Feb 25, 2026, 14:41 PM -
YEARS LOST: QUANTIFYING THE HUMAN COST OF DELAYED GENETIC DIAGNOSIS
Feb 25, 2026, 14:41 PM -
DEVELOPING THE FIRST PRAGMATIC DOSE CONVERSION BETWEEN LONG-ACTING AND DAILY GROWTH HORMONE IN PREPUBERTAL CHILDREN WITH IDIOPATHIC SHORT STATURE: A JOINT MODELING METHOD USING REAL-WORLD DATA IN CHINA
Feb 25, 2026, 14:41 PM -
DEVELOPING DIRECT EQUITY WEIGHTS FOR COST-EFFECTIVENESS ANALYSIS: RESULTS FROM A US-BASED DISCRETE CHOICE EXPERIMENT
Feb 25, 2026, 14:41 PM -
EFFECT OF WOUND EXUDATE SEVERITY ON TIME TO COMPLETE HEALING IN DIABETIC FOOT ULCERS: A REAL-WORLD LONGITUDINAL ANALYSIS (EXACT STUDY)
Feb 25, 2026, 14:41 PM -
ACCELERATING EVIDENCE GENERATION: LEVERAGING LLMS FOR FULL-TEXT STUDY SELECTION
Feb 25, 2026, 14:41 PM -
GLP-1RA AND RISK OF INCIDENT OPIOID USE DISORDER IN T2D: IMPLICATIONS FOR DRUG REPURPOSING
Feb 25, 2026, 14:41 PM -
REAL-WORLD COMPARATIVE OUTCOMES AND COSTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS IN TYPE 2 DIABETES PATIENTS WITH HEART FAILURE
Feb 25, 2026, 14:41 PM -
EARLY PATTERNS IN SECOND ORPHAN DRUG DESIGNATIONS FOLLOWING EXPANSION OF THE ORPHAN DRUG EXCLUSION
Feb 25, 2026, 14:41 PM -
A MULTI-COUNTRY RETROSPECTIVE CHART REVIEW OF TREATMENT PATTERNS AND RESOURCE USE IN PATIENTS WITH NEWLY DIAGNOSED PH-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA UNDERGOING FIRST-LINE CONSOLIDATION THERAPY
Feb 25, 2026, 14:41 PM
